Quintiles Transnational Holdings Inc (Q)

Q on New York Consolidated

19 Sep 2014
Price Change (% chg)

$0.32 (+0.56%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for Q


Quintiles Transnational Holdings Inc., is a provider of biopharmaceutical development services and commercial outsourcing services. The Company operates in two segments: Product Development and Integrated Healthcare Services. The Company’s Product Development segment operates as a contract research organization (CRO) focused... (more)


Beta: --
Market Cap (Mil.): $7,254.78
Shares Outstanding (Mil.): 127.28
Dividend: --
Yield (%): --


  Q Industry Sector
P/E (TTM): 24.02 144.28 33.56
EPS (TTM): 2.37 -- --
ROI: 20.20 -2.32 17.36
ROE: -- -6.96 18.23
Search Stocks

UPDATE 2-Product development unit woes overshadow Quintiles profit beat

* Co raises 2014 service revenue, adjusted EPS forecast (Adds details from conference call, analysts' comments and share movement)

31 Jul 2014

REFILE-Quintiles profit more than doubles on higher services revenue growth

July 31 - Quintiles Transnational Holdings Inc , the world's largest medical contract research provider, said its quarterly profit more than doubled, helped by higher growth in its integrated healthcare services segment.

31 Jul 2014

BRIEF-Basilea Pharmaceutica - enters into agreement with Quintiles for commercialization of Zevtera/Mabelio in Europe

July 21 - Basilea Pharmaceutica AG : * Says entered into agreement with Quintiles for commercialization of

21 Jul 2014

Earnings vs. Estimates

Search Stocks